Sandoval, J., Torbicki, A., Souza, R., Ramírez, A., Kurzyna, M., Jardim, C., … Pulido, T. (2012). Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension. Pulmonary Pharmacology & Therapeutics, 25(1), 33–39. https://doi.org/10.1016/j.pupt.2011.10.002

Sandoval, Julio, Adam Torbicki, Rogerio Souza, Alicia Ramírez, Marcin Kurzyna, Carlos Jardim, Carlos Jerjes-Sánchez Díaz, Simon A. Teal, Lie-Ju Hwang, and Tomas Pulido. “Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension.” Pulmonary Pharmacology & Therapeutics 25, no. 1 (February 2012): 33–39. https://doi.org/10.1016/j.pupt.2011.10.002.

Sandoval J, Torbicki A, Souza R, Ramírez A, Kurzyna M, Jardim C, et al. Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension. Pulmonary Pharmacology & Therapeutics. 2012 Feb;25(1):33–9.

Sandoval, Julio, et al. “Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension.” Pulmonary Pharmacology & Therapeutics, vol. 25, no. 1, Elsevier BV, Feb. 2012, pp. 33–39. Crossref, doi:10.1016/j.pupt.2011.10.002.

Sandoval J, Torbicki A, Souza R, Ramírez A, Kurzyna M, Jardim C, Jerjes-Sánchez Díaz C, Teal SA, Hwang L-J, Pulido T. Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension. Pulmonary Pharmacology & Therapeutics. Elsevier BV; 2012 Feb;25(1):33–39.